Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Acorda Therapeutics Inc.

    NASDAQ: ACOR · Real-Time Price · USD
    0.66
    -0.21 (-24.14%)
    At close: Apr 03, 2024, 3:59 PM

    Acorda Therapeutics Statistics

    Share Statistics

    Acorda Therapeutics has 1.24M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 1.24M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 1.22M

    Failed to Deliver (FTD) Shares

    n/a
    		 5,001

    FTD / Avg. Volume

    n/a
    		 3.98%

    Short Selling Information

    The latest short interest is 8.1K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 8.1K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 2.34

    Valuation Ratios

    The PE ratio is -0.01 and the forward PE ratio is null. Acorda Therapeutics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.01

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.03

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 -0.02

    P/FCF Ratio

    n/a
    		 -0.22

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Acorda Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.33, with a Debt / Equity ratio of -1.21.

    Current Ratio

    n/a
    		 0.33

    Quick Ratio

    n/a
    		 0.26

    Debt / Equity

    n/a
    		 -1.21

    Debt / EBITDA

    n/a
    		 22.72

    Debt / FCF

    n/a
    		 -13.4

    Interest Coverage

    n/a
    		 -0.74

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,153,264.71

    Profits Per Employee

    n/a
    		 $-2,478,960.78

    Employee Count

    n/a
    		 102

    Asset Turnover

    n/a
    		 1

    Inventory Turnover

    n/a
    		 2.85

    Taxes

    Income Tax

    n/a
    		 -43.17M

    Effective Tax Rate

    n/a
    		 14.58%

    Stock Price Statistics

    The stock price has increased by -24.91% in the last 52 weeks. The beta is 1.46, so Acorda Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.46

    52-Week Price Change

    n/a
    		 -24.91%

    50-Day Moving Average

    n/a
    		 1.48

    200-Day Moving Average

    n/a
    		 2.07

    Relative Strength Index (RSI)

    n/a
    		 45.91

    Average Volume (20 Days)

    n/a
    		 125,680

    Income Statement

    In the last 12 months, Acorda Therapeutics had revenue of 117.63M and earned -252.85M in profits. Earnings per share was -203.59.

    Revenue

    n/a
    		 117.63M

    Gross Profit

    n/a
    		 71.59M

    Operating Income

    n/a
    		 -23.26M

    Net Income

    n/a
    		 -252.85M

    EBITDA

    n/a
    		 8.4M

    EBIT

    n/a
    		 -233.49M

    Earnings Per Share (EPS)

    n/a
    		 -203.59
    Full Income Statement

    Balance Sheet

    The company has 30.36M in cash and 190.9M in debt, giving a net cash position of -160.54M.

    Cash & Cash Equivalents

    n/a
    		 30.36M

    Total Debt

    n/a
    		 190.9M

    Net Cash

    n/a
    		 -160.54M

    Retained Earnings

    n/a
    		 -1.19B

    Total Assets

    n/a
    		 81.58M

    Working Capital

    n/a
    		 -175.48M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -13.98M and capital expenditures -264K, giving a free cash flow of -14.25M.

    Operating Cash Flow

    n/a
    		 -13.98M

    Capital Expenditures

    n/a
    		 -264K

    Free Cash Flow

    n/a
    		 -14.25M

    FCF Per Share

    n/a
    		 -11.47
    Full Cash Flow Statement

    Margins

    Gross margin is 60.86%, with operating and profit margins of -19.78% and -214.95%.

    Gross Margin

    n/a
    		 60.86%

    Operating Margin

    n/a
    		 -19.78%

    Pretax Margin

    n/a
    		 -251.65%

    Profit Margin

    n/a
    		 -214.95%

    EBITDA Margin

    n/a
    		 7.14%

    EBIT Margin

    n/a
    		 -19.78%

    FCF Margin

    n/a
    		 -12.11%

    Dividends & Yields

    ACOR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ACOR.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 5, 2023. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Jun 5, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -23

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist